Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
NCT00005056
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
DRUG:
bryostatin 1
Sponsor
Cancer Research UK